Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synthetic Studies toward the Anacolosin Family of Clerodane Diterpene Natural Products.

Created on 27 Jun 2026

Authors

Nathan Schmitt, Julia B DiSapio, Uttam K Tambar

Published in

The Journal of organic chemistry. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

The anacolosins are an underexplored family of clerodane diterpenes with intriguing bioactivity and unique structural complexity. These molecules present a dense architectural challenge, featuring seven stereogenic centers and a distinctive five-membered bis-acetal ring system within their tricyclic core. We describe here the successful development of a scalable synthesis that completes two of three intended phases toward the total synthesis of the anacolosins. Obstacles that were overcome include the navigation of the steric demands of a Diels-Alder cycloaddition and exploiting inherent torsional strain to achieve high selectivity during a critical bridgehead allylation. Investigations into a late-stage oxidative reorganization sequence provided unique triacetal intermediates resembling those of the natural product scaffold, which taught valuable chemical lessons in the delicate balance of electronic and steric factors governing these complex scaffolds. This research establishes a clear trajectory for accessing the anacolosin family and offers critical insights into the reactivity and stability of highly functionalized decalin systems.

PMID:
42363887
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement